GEBEFLUC

This brand name is authorized in Nigeria.

Active ingredients

The drug GEBEFLUC contains one active pharmaceutical ingredient (API):

1	Fluconazole UNII 8VZV102JFY - FLUCONAZOLE
	Fluconazole is a triazole antifungal agent. Its primary mode of action is the inhibition of fungal cytochrome P-450-mediated 14 alpha-lanosterol demethylation, an essential step in fungal ergosterol biosynthesis.
	Read more about Fluconazole

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-5598	Capsule	GEBEFLUC-150 CAPUSLES CAP 150 mg 1x1capsule	19 RNW-PP-258711 GEBEFLUC-150 CAPUSLES FLUCONAZOLE USP 150MG fluconazole usp 150mg, (Excipients: Starch Pregelatinised BP, Lactose BP, Magnesium Stearate BP, Colloidal Anhydrous Silica BP, Sodium Starch glycolate) A4-5598 Drugs Imported Products 1x1capsule Prescription Only Medicine (POM) 6/2/2022 GBGL PHARMA LIMITED, OGUNTONA CRESCENT GBAGADA PHASE 1 LAGOS LAGOS 25432112 gbglpharmaltd2018@outlook.com Imperia Lifesciences Pvt. Ltd, SURVEY NO. 750/1, AHMEDABAD-MEHSANA HIGHWAY, VILLAGE-INDRAD, CHHATRAL -382721, DIST, MEHSANA, INDIA, India	07/07/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J02AC01	Fluconazole	J Antiinfectives for systemic use → J02 Antimycotics for systemic use → J02A Antimycotics for systemic use → J02AC Triazole and tetrazole derivatives
Discover more medicines within J02AC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-5598